Health
Innovent Announces First Patient Dosed in Phase III Pivotal Trial of IBI310 (CTLA-4) Combined with TYVYT® (sintilimab injection) for the Treatment of First-line Advanced Hepatocellular Carcinoma
SAN FRANCISCO and SUZHOU, China, Feb. 9, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...
2021-02-09 08:00
8199
Proxima Ventures and Co-win Ventures invest in Bioelectronica® Corporation to accelerate pharmaceutical discovery and development
RENO, Nev., Feb. 9, 2021 /PRNewswire/ -- Bioelectronica Corporation ("Bioelectronica") today announced the closing of an investment by Proxima Ventures and Co-win Ventures to advance the company's innovations in digital biochemistry, from novel assay development to scalable electrofluidics. The ...
2021-02-09 04:46
2860
8 Growth Opportunities in the Healthcare and Life Sciences Industry to Watch Out for in 2021
Frost & Sullivan experts present strategic insights on key trends such as virtual care, vaccines, hospital efficiency solutions, digital biomarkers, and microbiome therapeutics SANTA CLARA, Calif., Feb. 9, 2021 /PRNewswire/ -- Due to the impact of the COVID-19 pandemic, 2020 was an unforgiving b...
2021-02-09 01:43
272
Peloton Interactive, Inc. Announces Proposed Private Offering of $600.0 Million of Convertible Senior Notes Due 2026
NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Peloton Interactive, Inc. ("Peloton") (Nasdaq: PTON) today announced its intention to offer, subject to market conditions and other factors,$600.0 million aggregate principal amount of Convertible Senior Notes due 2026 (the "notes") in a private offering (th...
2021-02-08 21:47
7194
Cooperation Agreement with Terumo Blood And Cell Technologies to Promote and Sell Osteopore Products
Highlights: * Cooperation Agreement with Terumo Blood and Cell Technologies to promote and sell both companies complementary regenerative products inAsia-Pacific. * Terumo Blood and Cell Technologies' products will be used to concentrate a patient's bone marrow and mixed into Osteopore scaffo...
2021-02-08 21:21
1783
Longevity Acquisition Corporation Announces 4D pharma Clinical Trial Collaboration and Supply Agreement for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that onFebruary 8, 2021, 4D pharma plc (AIM: DDDD) ("4D pharma"), a pharmaceutical company leading the development of Liv...
2021-02-08 21:00
7464
Basecare Lists First Gene Sequencing Stock on Hong Kong Stock Exchange Ushering in Licensed Era of China's Third-Generation IVF Kit
HONG KONG, Feb. 8, 2021 /PRNewswire/ -- Basecare (Suzhou Basecare Medical Corporation Limited), an innovative assisted reproductive genetic testing enterprise, today officially listed on the main board of HKEX (HKG: 2170). Approximately 66.667 million shares were issued and total funds raised was...
2021-02-08 19:32
5347
CareCapital appoints Bindusaran as Executive Director
HONG KONG, Feb. 8, 2021 /PRNewswire/ -- CareCapital Advisors Limited ("CareCapital") announces the appointment of Mr. A P A Bindusaran as Executive Director and Head of DSO Clinical and Business Development. Prior to joining CareCapital, Mr. Bindusaran spent 16 years in R&D, clinical affairs, tre...
2021-02-08 18:14
1589
Inova Appoints Claude Basset as Chief Product Officer
LYON, France, Feb. 8, 2021 /PRNewswire/ -- Inova, the market-leading partnering platform for the pharmaceutical and biotech industry, today announced that Claude Basset has joined their leadership team as Chief Product Officer. Inova is a French Tech success story that, now in its 10th year, ha...
2021-02-08 16:00
1352
Orpha Labs AG Initiates Compassionate Use Program for ORL-101 in Leukocyte Adhesion Deficiency Type II (LAD-II)
First Patient to Receive ORL-101 in Israel This Week BAAR, Switzerland, Feb. 8, 2021 /PRNewswire/ -- Orpha Labs AG today announced its compassionate use program to make ORL-101 available to physicians providing care for Leukocyte Adhesion Deficiency Type II (LAD-II) patients. ORL-101 is a novel ...
2021-02-08 15:00
2266
Zamst announces sponsorship with Yuji Nishida, Professional Volleyball Player
TOKYO, Feb. 8, 2021 /PRNewswire/ -- Nippon Sigmax Co., Ltd., owner of Zamst, a
brand of athletic braces and care products headquartered inTokyo, Japan, has
entered a sports sponsorship agreement withYuji Nishida, Japanese men's
professional volleyball player for JTEKT Stings in V.League.
2021-02-08 14:00
5150
AXA launches "Wealth Ultra Savings Plan (2-year Pay)"
HONG KONG, Feb. 8, 2021 /PRNewswire/ -- AXA Hong Kong and Macau today announced the launch of "Wealth Ultra Savings Plan (2-year Pay)"("Wealth Ultra (2-year Pay)"), a participating life insurance plan with a short premium payment term of two years. Customers can enjoy sustainable wealth growth wi...
2021-02-08 13:55
2413
iHerb officially launches an online activity named "good fortune shopping day" in the coming new year of ox
SINGAPORE, Feb. 8, 2021 /PRNewswire/ -- The year of the mouse rings out and the year of the ox rings in, and the Spring Festival of 2021 is drawing near soon. Through the epidemic haze in 2020, people value health much more and more. There's nothing better than giving our relatives and friends he...
2021-02-08 11:48
2036
Infinitus Mutual Help Organization Celebrates Its 10th Anniversary
GUANGZHOU, China, Feb. 8, 2021 /PRNewswire/ -- On January 31, 2021, a special exhibition celebrating the 10th anniversary of the founding of Infinitus Mutual Help Organization (Infinitus MHO) was held at Infinitus Xinhui Production Base in Jiangmen, Guangdong province. The goal of the six-month-l...
2021-02-08 09:00
2182
A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan
TOKYO, Feb. 8, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced the completion of a clinical study inJapan for a product using Terumo's automated injection device developed in collaboration with Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin). Kyowa Kirin initiated the clinica...
2021-02-08 09:00
3275
Proposed Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab
SHANGHAI and GAITHERSBURG, Md., Feb. 5, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the commencement of a proposed registered underwritten pu...
2021-02-06 06:27
9340
Hidrox(R), a proprietary olive polyphenols formulation may help in managing COVID-19 pandemic
HAYWARD, Calif., Feb. 6, 2021 /PRNewswire/ -- Oliphenol LLC, Hayward, California , announces the publication of a discovery focused upon the SARS-CoV-2-inactivating activity of Hidrox®, an olive polyphenols formulation for a potential treatment against SARS-CoV-2 infection. The Paper, "The SARS-C...
2021-02-06 00:17
2995
I-Mab Announces Multiple Clinical Advancements of Its Differentiated CD73 Antibody Uliledlimab in China and the U.S.
SHANGHAI and GAITHERSBURG, Md., Feb. 5, 2021 /PRNewswire/ -- I-Mab (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics, today announced multiple clinical advancements for its proprieta...
2021-02-05 21:00
5735
111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services
SHANGHAI, Feb. 5, 2021 /PRNewswire/ -- On January 11, 2021, 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, and Jilin Baiyi Doctor Group Management Co., Lt...
2021-02-05 19:00
5171
Thomson X Inks Strategic Partnership with Singapore-Based Startup Plano and Set Sights on Managing Myopia in Asia
SINGAPORE, Feb. 5, 2021 /PRNewswire/ -- Thomson X ("TX"), a wholly-owned subsidiary of SGX Mainboard-listed Thomson Medical Group Limited (the "Group"), today announced a strategic partnership with Plano Pte Ltd (" Plano"), a Singapore-based HealthTech startup. The collaboration will leverage on ...
2021-02-05 18:00
3357
Week's Top Stories
Most Reposted
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 291 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 289 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
Most Read
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
10141
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
2024-11-07 11:34
7500
XTEP's First Mono Store in Malaysia Comes to Puchong
2024-11-07 10:08
6214
